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ABSTRACT
Intravenous bisphosphonates (BP) play a key role in the treatment of bone metastases. As 
a long-term side effects BP, a form of avascular osteonecrosis of the jaw has been reported. 
Although, invasive oral local procedures are often present in clinical history of patients suffering 
from bisphosphonates-related osteonecrosis of the jaws (BRONJ), about up to 50% of BRONJ 
are spontaneous. We report a case of a 68-year-old female with a spontaneous wide bone 
sequestration of the left mandibular body onset after infusion of zoledronic acid for 18 cycles 
for osseous metastasis due to metastatic anaplastic thyroidal carcinoma. Surprisingly the 
clinical aspects of the patient initially reminded us of the famous pathology described in 1899 
called phossy jaw. This case is remarkable not only for the spontaneity of the osteonecrosis, 
but, above all, for the clinical similarity with cases of phossy jaw, described for the first time 
in the literature, thereby suggesting a potential common pathogenesis.
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following laceration of the left side of the tongue by the 
sharp edges of the left, exposed mandibular bone. During 
anamnesis, the patient referred that the pain in the left 
mandibular region appeared in July 2007, but no medical 
consultation was asked by the patient; it was apparently 
spontaneous and the patient had no dental treatment 
during the period of the infusion of zoledronic acid. The 
painful symptoms and the alleged osteonecrosis were 
never subjected to any medical treatment until January 
2009. While being physical examined, the patient appeared 
partially obnubilated, with an asymmetrical face with 
moderate swelling of the tissues in the left emi-mandibular 
region. Foetor ex ore was also observed. The clinical 
aspects of the patient initially reminded us of the famous 
pathology described in 1899 in workers exposed to white 
phosphorus and called phossy jaw [Figures 1a and 2]. An 
intraoral examination revealed a wide exposure of the left 
emi-mandibular body, which was freely mobile protruding 
from the mouth [Figure 1b].[1]
The patient underwent various radiological tests and a 
chest X-ray revealed macro- and micro-nodular opacities 
in both lung fields, which were subsequently reported 
as metastatic lesions. Maxillofacial computerized axial 
tomography with tridimensional reconstruction revealed 
a wide bone sequestration of the left mandibular body 
with, extending from the neck of mandibular condyle 
to the symphysis, to include the coronoid process and a 
lacunar area with a well-defined margin in the upper left 
CASE REPORT
A 68-year-old Caucasian female was referred from the 
Oncology Department to the Maxillo-Facial Surgery 
Department in January 2009 for the evaluation and treatment 
of mandibular osteonecrosis. She had been diagnosed with 
metastatic anaplastic thyroidal carcinoma with multiple 
lung and osseous metastasis without any involvement of the 
jaw; comorbidity included only arterial hypertension. The 
patient had undergone a total thyroidectomy and received 
chemotherapy with combination of cisplatin (CDDP) 
60 mg/m2 and epirubicin (EPI) 75 mg/m2 every 3-4 weeks. She 
had also undergone a monthly 4-mg infusion of zoledronic acid 
for 18 cycles and an antalgic therapy had also been performed.
The patient was referred for us for observation due to the 
intense pain experienced during chewing and swallowing 
shOrt cOmmunicatiOn
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parietal region [Figure 3]. After an intravenous antibiotic 
prophylaxis and under local anesthesia, thought a buccal 
approach a sequestrectomy followed by a curettage of the 
residual cavity with the removal of the other small bone 
fragments of size <1 cm were performed [Figure 2]. The 
histopathological examination of the specimen demonstrated 
bone necrosis with no evidence of metastatic disease. Due to 
the probable release of bacterial toxins, the patient showed 
a worsening state of obnubilation, leading to torpor and 
lethargy for about 4 hours after surgery, followed by a 
spontaneous resolution with an improvement in the clinical 
conditions. After two days the patient was discharged and 
after a 2-month period of follow-up, no further regions of 
necrosis were detected.
DISCUSSION
Bone metastases are one of the major causes of morbidity 
in patients with breast, prostate, lung, renal and thyroidal 
cancer. From their first introduction in 1995,[2] intravenous 
bisphosphonates (BP) have played a key role in the 
standard treatment for metastatic disease spread to the 
bone from solid cancers, in treatment of multiple myeloma 
and management of malignant hypercalcemia. For BP 
it has been demonstrated they have a favorable impact 
both on the natural history of the disease and the quality 
of life, decreasing pain and skeletal-related events. In 
addition to well-known side effects (such as a flu-like 
syndrome, alterations in creatinine and hypocalcemia), 
the use of BP has also been linked to the development of 
a particular form of avascular osteonecrosis of the jaw as a 
long-term complication and called bisphosphonate-related 
osteonecrosis of the jaws (BRONJ).[2,3]
Although the first description of BRONJ was ascribable to 
Marx and Stern in 2002,[4] BRONJ may be considered an 
analogous to the historically-documented, occupational 
industrial disease recognized more than 100 years earlier 
and called phossy jaw.[5] This term was referred to a 
nonhealing bone exposures, localized only in the mouth, 
which had been caused by exposure to white phosphorus 
during the manufacture of matches.[1,5] The first case 
series was reported in Vienna in 1845 and, of the 22 cases 
analyzed, approximately 11% of those exposed to white 
phosphorus developed the disease. In that pre-antibiotic 
era, phossy jaw was fatal in about 20% of cases, usually due 
to septicaemia or meningitis. In 1910, in the United States, 
John Andrews published a report of 150 cases of phossy 
jaw from 15 of 16 match factories then in operation.[1,5] 
Thereafter, the substitution of white phosphorus with an 
amorphous red phosphorus, which did not possess the toxic 
properties of white phosphorus, reduced the incidence of 
jaw osteonecrosis.[1,5]
After many years, the use of BP in medicine coincided with 
the onset of a disease, which was clinically similar to phossy 
jaw, and termed BRONJ. Likely, in order to emphasize 
the common etiology and the clinical similarity between 
the two historically distinct clinical entities, for the new 
entity the terms osteochemonecrosis or bis-phossy jaw were 
also used. As regards phossy jaw chronic daily exposure 
to airborne phosphates in miners was probably able to 
cause an accumulation of phosphorus compounds in the 
Figure 2: The wide bone sequestration of the left mandibular body 
obtained after sequestrectomy remembering the phosphorus necrosis 
of entire lower jaw excised by Mr McCarthy in 1884 (London Hospital 
Medical College Museum)[1]
Figure 1: (a) The patient appeared with an asymmetrical face with 
moderate swelling of the tissues in the left emi-mandibular region. 
The clinical aspect of our patient was similar to the necrosis of the 
jaws observed in workers exposed to white phosphorus and so called 
phossy jaw[1]; (b) the intraoral examination revealed a wide exposure 
of the left emi-mandibular body, which was freely mobile protruding 
from the mouth
ba
Figure 3: (a) Maxillo-facial computerized axial tomography with 
tridimensional reconstruction. Wide bone sequestration of the left 
mandibular body with, extending from the neck of mandibular condyle 
to the symphysis, to include the coronoid process. (b) Panoramic X-ray 
of the jaws and (c) Computed tomography of the mandible revealed 
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bone, inducing the same clinical picture as today related 
to the medical use of BP. In particular, the explanation 
for the similarity between the two conditions can be 
found in the chemical features, because white and yellow 
phosphorus molecules [P4O10] react with [H2O] and [CO2] 
(continuously produced, introduced and expelled during 
respiration), and with common amino acids (i.e., lysine) 
in humans to produce a powerful amino-BF, which is 
comparable to modern pamidronate or alendronate.
Today, the etiology of BRONJ remains still unknown and 
the multi-factorial pathogenesis is related to many local or 
general factors, including the impairment of local immunity 
of the jaw bone, the suppression of bone turnover, the 
inhibition of angiogenesis, the BP toxicity to soft tissues, 
the direct BF toxicity to bone, and fungal or bacterial 
infections.[4,6]
It is a clear evidence that the most reported risk factors for 
the development of BRONJ are the assumption of BP, and 
in particular the potency and the route of administration 
of BP (0.01-0.04% for oral BP vs 0.8-12% for intravenous 
BP)[4] associated with an history of tooth extractions or other 
dento-alveolar surgical procedures; but in the last 3 years 
there has been an increasing observation that over 40% of 
BRONJ are spontaneous or at least non-surgery triggered.
In many of these latter cases, it is impossible to consider 
the connection with dental diseases (periodontal 
and/or endodontic infections), local trauma (i.e., poor-fitted 
dentures), poor oral hygiene or anatomical abnormalities 
which act on a jaw bone made susceptible by BP.[4,6]
The anti-angiogenic activity and the excessive reduction bone 
turnover induced by BP remain the two main mechanisms 
which may predispose jaw bones to osteonecrosis. The 
alteration of the angiogenesis in newly formed hard and 
soft tissues may have important effects on the quality and 
quantity of bone perfusion, resulting in an impaired response 
of osseous tissue to surgical intervention, local trauma 
and infections.[3] Any wound connected to endodontic 
or periodontal infection or denture trauma may expose 
the edentulous ridge of the mandibular and maxillary 
bones, made more susceptible by the assumption of BP, to 
a micro-organism infection with higher risk to develop a 
BRONJ, which may clinically mimic and so be misdiagnosed, 
at least in its initial phases, with a dental disease and 
eventually later treated with a tooth extraction.[4] The result 
appears as a non-healing postextractive site diagnosed as 
BRONJ.[4]
Hence, on the basis of these considerations and according 
to the experts’ opinion, it is possible that the first changes in 
the jaw bones induced by BP may have already developed 
before surgical procedures are performed, being these latter 
a possible consequence of a pre-existing BRONJ and not a 
precipitating factor.[6]
Although BRONJ usually may manifest itself with exposed 
necrotic bone, associated or not with suppuration and pain, 
more recently there have been reported cases of BRONJ 
without bone exposure, at least in their early stages. This 
variant of BRONJ may be characterized by pain, sinus 
tract, tissue swelling which could precede of weeks or 
months the onset of frank bone exposure.[7] The case 
reported is remarkable not only for the spontaneity of the 
osteonecrosis, unrelated to any invasive local procedure, 
but, above all, for the clinical similarity with cases of phossy 
jaw [Figures 1a-b and 2],[1] thereby evocating a potential 
common pathogenesis.
Despite the fundamental role of BP in the management 
of serious diseases and their complications, it is extremely 
important to consider the existence of this long-term 
complication which can be often difficult to manage. 
Furthermore, due to the BP antineoplastic properties, 
their use will probably increase in the future, and thus the 
education and collaboration among the specialists involved 
(e.g., dentists, maxillofacial surgeons and oncologists) is 
crucial to preventing and eventually treating this devastating 
condition.
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